Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hi T-Tucker,
Thank you for the kind words and welcome to CNBX!!
I was researching MMJ in late 2014 and found CNBX was by far the best company long term. Even over GWPH. I invested in early 2015.
If you go back through my posts over the past couple years, you can see my research regarding everything from how Wana Caps (CNBX pill) is a winner for Human Resources issues, to how CNBX is personalizing cancer treatment.
I hope we all continue to have a fantastic ride with this fantastic company.
Take care, Jim
Aha, yes, iltghwism, thank you for mentioning that. That is advice I forgot to add.
As iltghwism mentioned, when playing the tax game, you have to wait 30 days to buy back in to the same stock to get the tax break.
Take care, Jim
Sorry to hear that Brussangler but the upside is that, with it being this close to the end of the year, you will be able to claim that $ 1,500 loss on your taxes.
I have actually sold stock at a loss at the end of a calendar year to take the loss on my taxes when I know a stock isn't going to go up before Dec. 31st.
Taking the loss, which lessens my taxes, in effect allows you to break even and then you have your money freed up to buy back in.
Hopefully that approach works for you, if not in buying back in to something after the first of the year, at least in writing it off on your taxes.
Take care, Jim
Hi Bigfred1,
At this time the personalization process works via biopsies.
Physicians are able to ship biopsies harvested from patients to CNBX and CNBX will analyze the biopsy and create a treatment that is specific to what the patient needs.
I did the same thing over a year ago for my extreme allergies. They drew blood, analyzed it for my various allergies, created a treatment that even allotted for building up a tolerance to the treatment (one of my main issues with traditional treatments, as after a few months I had to take more to keep them working) and I get 3 shots a week to treat my extreme allergies.
Breathing the best I have in over 30 years, my snoring has stopped, and my wife lets me sleep in our bedroom again.
Personalization saved my life!!! And that is what CNBX is doing for cancer to replace chemo, radiation, etc.
Fantastic day!! Take care, Jim
Serious question: Typically dilution is done to raise capital so a company can be in a position to do positive things.
However, this company is horrible about promoting itself when it does positive things.
So my question is: Is there anything the company is doing or on the company's horizon that they are gearing up for that is going to make up for the dilution?
I'm coming up on a year in, have only added, never sold a share. So while I am long, I am trying to find out what this company is doing but can't bring itself to brag about well enough to help itself.
Thank you for any valid info!! Jim
This post is why we need a "like" button.
Lowest volume that I have seen for awhile. 242,587 as of 12 pm EST.
Fantastic analytical answer!! Thank you!!
As I read the board each day, I am trying to get a feel for what makes our brethren make the decisions they make, what is of most interest, etc.
With a company like VDRM, I feel understanding the company's investors is part of understanding the company and its ups and downs.
Thank you for taking the time to give such a well thought out answer! I appreciate anyone willing to give the time to contribute to our IHUB knowledge base.
Merry VDRM Christmas to us all! Jim
An open question for all: With OTC stocks like VDRM, do you mostly look at historical data (ie, it did well last February, so it will possibly/probably do well this February) or based on current VDRM news as it comes in, with historical data being of less relevance?
Thank you for your time. Jim
Nice to see this quote in the article: "Even the current DOJ, which is opposed to legal marijuana, has said it does not wish to interfere with medicinal marijuana, and public support for medical marijuana has grown to an incredibly overwhelming majority".
The U.S. Government needs to wake up and realize that agriculture is one of the few areas we can truly compete in and that products like this will provide jobs from the fields through the science to the shelves and hospitals. So many jobs could be created, and our government wants other countries to have the first pick of these jobs for some reason.
Get Sessions and the DOJ out of this and let's make some money both as a stock investment and with jobs!!!!!!!!!!!!!!!
Happy Thanksgiving Everybody!!!!!!! Jim
I agree with the "Soon" and feel they need to slow use of that term.
As for dilution: In the spring/summer of 2017 I think they promised to not do any dilution until September 2017. To their credit, I think they held that promise... but of course have been diluting since September.
I may be wrong, but I think they held up on dilution for that span of time.
They simply need better folks pushing their good points and handling press and IR.
Take care, Jim
Vitastem is listed on the link you provided!! There is a Biogenx pic of the product with what is listed as "3rd Degree Burn" with pics before and after use. Had the info below as part of the ad:
"Vitastem is a Top Rated Local® Skin #Medication! Use it on your #burns,# acne, #infections, and more!"
https://web.stagram.com/tag/healingcream
So IR doesn't research their own posts regarding the case well enough to know the gender of the judge but feels informed enough to comment on the proceedings.... GREAT!!!
Thank you for running that info down and confirming it SchlumpyStock-Picker. I am heavily invested in VDRM but I also take little things like this into account when considering a source and the data they proclaim.
Whoever their IR person is that sent that email should not be getting paid for doing IR as they are not informed enough to do so.
Hopefully, the case truly does go away in our favor soon.
Take care, Jim
Gifton Thursday, 11/09/17 11:46:11 PM
Re: Post # 31037
ViaDerma Investor Relations <info@viadermalicensing.com>
12:53 PM (10 hours ago)
to me
Hi XXXXX
We expect to have some news updates out soon. FDA and production hurdles have been cleared. The lawsuit is on the hands of judge awaiting his decision whether to dismiss the case.
Thanks
---
ViaDerma Investor Relations
310-734-6111
Has the judge on the case changed? I thought it was a woman.
Can anyone advise on this? It is little things like this that reflect whether an IR rep is just typing a reply or actually giving legit info.
Thank you, Jim
One of the better CNBX articles. Thank you for posting this Midnightmatt!!
Jim
I agree with everything you said. As far as what the "big deal" was about my post: CNBX is typically only covered by low-end news brokers like PR Newswire. Today, they were featured on the Dow Jones Newswire.
Instead of only being featured by a news source we hadn't heard about until coming here.... they were featured on a wire that we have all heard about since kids on the nightly news.
That was what I was making over.
$ 10 a share is what is being forecasted when the patent information locks down, based on AXIM going to $ 19 when it got its patents and didn't even have a tangible product. (This is not my forecast. I typically do not forecast prices, just share/disseminated news).
Looking forward to that as soon as possible.
Take care, Jim
CNBX makes it onto Dow Jones Newswires!!! Of course, the news of the day would be covered by PR Newswire, but nice to see it on Dow Jones as well. Lifted post below from Etrade.
*DJ Cannabics Pharmaceuticals Files Patent Application on Cannabinoid Modulation of the Microbiome
Nov 08, 2017 10:15:00 (ET)
(MORE TO FOLLOW) Dow Jones Newswires (212-416-2800)
November 08, 2017 10:15 ET (15:15 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
"FDA & court stuff over"... has the court issue been resolved? I had not heard about that.
Please confirm.
Thank you, Jim
retired early Tuesday, 11/07/17 12:31:50 PM
Re: kerfluffel post# 30989
Post #
30990
of 30996 Go
Sales data, new product releases, FDA and court stuff over with and Canada patch due very soon. Great long term investment. :)
Great news heading into year-end!
Thank you for posting this Midnightmatt!!
Jim
War chest of 3.2 million on the books!
http://financeregistrar.com/cannabis-spotlight-cannabics-pharmaceuticals-inc-otcmktscnbx/
Check out this article from April 2016 about where GWPH was and was expected to go.
Doesn't CNBX sound like it is poised to do every bit this much and on some points has already surpassed GWPH?
GWPH is at $ 113 pps today... Based on this article, CNBX should skyrocket.
https://www.marketwatch.com/story/five-things-to-know-about-what-could-be-americas-first-cannabis-derived-drug-2016-03-15
Ah, ok, thanks!! I was wondering why we were suddenly off schedule. Forgot that there is no 10Q when the yearly is taking its place.
Thanks again, Jim
I completely agree. I think it was someone putting it on Amazon to be able to say it was on Amazon.
Take care, Jim
You laugh, but if you think there are not those among us that would put it on Amazon to be able to say it is on Amazon, you have not seen the paint jobs we've been enjoying lately.
We now return you to your regular "I see this going over .2 tomorrow, I mean .02 tomorrow, go #VDRM. We'll get news SOON!!" programming.
:)
I wonder why so late? Seemed to be on a pretty regular 3-month schedule... ????
To answer everyone questioning Vitastem on Amazon: It really was Vitastem (not the comparatively named Vitastim). It was on there for a day or so. Below is what I think took place:
I figure someone that bought it to see if it would really arrive turned around and offered it for sale on Amazon to recoup their money while at the same time being able to have the product appear on Amazon. Once it sold, their link went away.
A pretty smart double dip move, confirming it exists for themselves and being able to claim it is on Amazon while recouping their $$.
Selling on Amazon is pretty easy so I wouldn't be surprised to see it appear there again on occasion, especially if people are able to get the 50% off coupons I have read about on here and then sell it for the $ 99 and double their money while promoting it on the biggest selling site in the world.
Take care, Jim
Per previous 2017 10Q releases, we are due any time.
While news included in the report is officially not supposed to leak out until the release, it always seems to do so a few days before release. In part because data in the release is somewhat available. More on that below.
Since the stock suddenly jumped up over 30%, my guess is the news is going to be good. This only makes sense, as this report will reflect another quarter of zero debt, money in the bank, great biopsy test results, and continued sales of products in market that are reaching more states/regions than reflected in the previous 10Q.
Even though a state passes that MMJ is legal, it takes time to ramp up distribution in those states. So Arizona, for example, is just now coming online a year after passing the law. Ohio passed it as well last November but has bungled roll out. So, you will see spikes as states get their crap together post-legalization, and CNBX will be sold there once the states get dispensaries set up.
Do not be fooled by those that try to point out that CNBX hasn't spent much on research. CNBX research is being performed in conjunction with Israel's Ministry of Health, which picks up a lot of the costs.
These are facts that are trackable between reports but are more apt to make it into news articles when released all at once and thus pps spikes when positive reports are released or are about to be released. (Many of us watch hours of football on Saturday, yet we still turn on Sports Center to get bite-sized recaps of what we may already know. The same is true with the press and press releases).
Previous 2017 10K releases took place on a Tuesday (Jan. 17th), a Friday (April, 14th) and a Monday (July 17th), so again, we are due any time.
I usually do not throw pps projections around, but if you want to get in under a dollar on this run, you're gonna want to get it done asap in my opinion. It may bounce a bit due to fomo's selling and buying, but all in all, there is no bad news, and there is actually a whiff of buyout/buy-in going around... which MAY BE why you haven't seen a 10Q yet if they are sealing a deal before year-end.
Take care, Jim
LOVE the 30% jump today!! Other than it is obviously worth a lot more than this, does anyone have a reason of why it broke out of its slump today?
We all so needed this with the sector handing us our collective asses over the past weeks!!!
Let me know if there is news I am not seeing.
Take care and thanks!! Jim
Ah, thank you!
Yes, I do not hold as much of that as I do CNBX, but I agree, it is bleeding off. My buy in of "O" was $ 1.60 pps.
I had just sold off my holdings in Lions Gate Films LGF due to they were going to split shares and used the holdings to buy in to VDRM, MCOA, and OWCP, along with taking some in cash.
Sold the MCOA at a $ 3,000 loss, holding the "O" but it's a huge loss as of now, and still holding out hope for "V".
CNBX was my first foray into MMJ, in early 2015. And I wish I would have bought and held a lot more!!!!!
Take care and thanks again, Jim
Showing my ignorance as always, but what is "O" in your comment "problem is O keeps bleeding and we dont know where is bottom can be. 30s or 20s"?
Thank you, Jim
I figure there is at least a 50% chance a big pharma firm will buy CNBX. It is simply doing too well and has too much support overseas to simply ignore it forever.
"If Big Pharma doesn't get involved, is there any hope for these companies to make really big gains?" For CNBX, yes. Here are reasons why:
1. They have the most human resources friendly product in a 12 hour long release pill. After legalization and all the other battles, the real battle begins when employers start saying you cannot bring MMJ products on their property, which they legally can do. You can take CNBX before and after work.
2. Ministry of Health in Israel supports CNBX and Israel is the only country with global export approval of MMJ. Even if just they support CNBX, it will continue to succeed.
3. CNBX has products in the market (Wana Caps, 5mg capsules, etc) as well as 100% success in the clinical trials where they have allowed physicians to send in biopsies, etc. Very few companies have as much going on that is as transparent and successful. (For example, you can visit clinicaltrials.gov to see up to date trial successes... recognize that fact with a lot of other MMJ's??? NO!)
I could go on and on, but there is a reason I got into this company in early 2015. The pills, the studies, the elimination of debt by a major investor... more going for it than any other MMJ I know. Why is CNBX not at least 1/3 the price of GWPH???
These are my DD and my opinion, but good things have been happening and everything is in place for that to continue!!
Take care, Jim
I am sure this shows my ignorance, but who/what is aaron?
"7) aaron about to give a huge buy signal"
Thanks, Jim
Who we need to reach is the military. If we could get the military to try the product in the field, VA hospitals, etc, we could get both a nice order as well as a very quick case study on how the product works on major wounds, etc.
Individual hospitals are great, but they keep individual records. The branches of the military are a standardized group that are huge fans of paperwork and record keeping.
Finding an in with military doctors to try the product and in turn order it in large quantities if they like it would be a huge get.
Fantastic. We need as much coverage of that type of news as we can get.
Thank you, Advisors! Jim
This posted 10/25/17 at Etrade regarding patents, etc:
Biotechs Develop Proprietary Systems to Drive CBD -2-
Oct 25, 2017 08:30:00 (ET)
NetworkNewsWire Editorial Coverage
NEW YORK, October 25, 2017 /PRNewswire/ --
Cannabics Pharmaceuticals (OTCQB: CNBX) provides diagnostic tools and bioinformatics to support practitioners and patients.
Also engaged in scientific and clinical research through its subsidiary, Grin Ultra, the company is developing cannabinoid-based medicine for cancer patients, examining efficacy through in-vitro studies and clinical trials.
Cannabics is currently studying the effect of its proprietary cannabis capsules on weight and appetite loss in cancer patients.
The company recently filed national phase patent applications for its proprietary cannabis-based cancer cell screening technology in the United States, Canada, Europe, Australia, China, India and Brazil.
I appreciate that insight liddymo. What is baffling me is that I got into this stock when it was based on a 12 hour long release pill. A great product but not the cure to cancer.
Over 2 years later, this stock is beating all others in appearing to be a possible treatment for cancer, 100% positive results so far.
So I would think it would be doing better than when it was just a 12 hour long release pill.
It is killing me because I too may have to sell some, at a gain no less, to cover taxes. I sold 50,000 shares of CNBX this year, along with others like VDRM, and now about the time I would be cashing some in around Jan. 1st, the stock is in the toilet.
I suppose everyone could be thinking that way, but the value of the stock should still be higher based on it's effectiveness and track record.
Thanks again, Jim
Does anyone have any news regarding contact with investor relations, etc or any idea regarding dilution etc of why this is dropping so?
Is there any hope for this turning around in the near future?
I have been with CNBX since early 2015 and this is the worst I have seen it in quite awhile. Typically I can point to reasons the company ebbs and flows, but this time, all things are positive except the pps.
Thanks, Jim
Yeah, it's been a bit of a grueling ride.
I got in between .03 and .15 and watched it go to $ 7.46 and then plummet back to today's value, so I completely understand your frustration.
The company has garnered a $ 3 million dollar investor that eliminated all of it's debt, it's studies have returned 100% apoptosis of all the cancers they have tested it on, and they have a number of products in market that are selling well in the U.S. and internationally.
They also have the approval of the Israeli Ministry of Health to do studies, and Israel is the only country that currently has global export rights, so they are doing everything right and then some.
You would think that they would be performing at least half as well as someone like GWPH that released a spray that only lasts 4 hours and hasn't had nearly the good press... yet currently sells for over $ 100 a share.
Enjoy the little one!! Take care, Jim
The answer really depends on how quickly you need the money.
If you can get by without touching this investment, you will probably be happy that you let it sit as it will bounce back to at least around $ 1 based on previous activity and has a good chance of surpassing where you got in, maybe by far.
If you need the money to make the rent and 50% will at least keep a roof over your head, then, of course, pull the plug and get out.
But if you are just worried for the sake of the investment, let it ride.
I got into OWCP @ $ 1.60 ... it sits at .30 something. I will probably not sell at a loss... unless I don't have the rent, so to speak.
I am just speaking on personal opinion.
Take care, Jim
In theory, anyone who can legally buy and resell the product can open an Amazon store and sell it.
Amazon has made it easy enough to operate your own "Amazon Store" that a lot of people cruise the internet for products like this, offer it on their store without having purchased it, and when someone places an order, they simply use Amazon Prime Free 2 Day Shipping to ship direct to the buyer, removing themselves as a middleman as far as receiving and shipping and simply collecting money in between.
The catch would be that, beyond being allowed to sell it, that they get it at a price that they can make a profit compared to someone ordering it direct from Biogenx.
If people do not know to order from Biogenx and do not know about the $ 99 price at Biogenx, they could, in theory, sell it for say $ 125 or $ 150 and for very little effort clear $ 25 to $ 50 per unit sold.
Take care, Jim